000 01403 a2200361 4500
005 20250515201334.0
264 0 _c20100406
008 201004s 0 0 eng d
022 _a1531-8257
024 7 _a10.1002/mds.22885
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSamadi, Pershia
245 0 0 _aBDNF levels are not related with levodopa-induced dyskinesias in MPTP monkeys.
_h[electronic resource]
260 _bMovement disorders : official journal of the Movement Disorder Society
_cJan 2010
300 _a116-21 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntiparkinson Agents
_xadverse effects
650 0 4 _aBrain
_xmetabolism
650 0 4 _aBrain-Derived Neurotrophic Factor
_xmetabolism
650 0 4 _aDisease Models, Animal
650 0 4 _aDyskinesia, Drug-Induced
_xmetabolism
650 0 4 _aEnzyme-Linked Immunosorbent Assay
_xmethods
650 0 4 _aFemale
650 0 4 _aLevodopa
_xadverse effects
650 0 4 _aMPTP Poisoning
_xdrug therapy
650 0 4 _aMacaca fascicularis
700 1 _aMorissette, Marc
700 1 _aLévesque, Daniel
700 1 _aDi Paolo, Thérèse
773 0 _tMovement disorders : official journal of the Movement Disorder Society
_gvol. 25
_gno. 1
_gp. 116-21
856 4 0 _uhttps://doi.org/10.1002/mds.22885
_zAvailable from publisher's website
999 _c19395508
_d19395508